-
Pfizer launches upstart with $103M, phase 3-ready drugs
- Source: Fiercebiotech
- 572
- September 27, 2017
-
Pfizer sues Johnson & Johnson, alleging anticompetitive practices to maintain a drug monopoly
- Source: Washingtonpost
- 701
- September 22, 2017
your submission has already been received.
OK
Subscribe
Please enter a valid Email address！
Submit
The most relevant industry news & insight will be sent to you every two weeks.
